Align Technology, Inc. (0HCK.L)
USD 153.23
(-0.05%)
USD 153.23
(-0.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.45 Billion USD | 4.55% |
| 2022 | 2.34 Billion USD | 1.17% |
| 2021 | 2.31 Billion USD | 45.34% |
| 2020 | 1.59 Billion USD | 38.22% |
| 2019 | 1.15 Billion USD | 44.39% |
| 2018 | 799.56 Million USD | 26.97% |
| 2017 | 629.72 Million USD | 57.13% |
| 2016 | 400.76 Million USD | 47.52% |
| 2015 | 271.67 Million USD | 34.62% |
| 2014 | 201.81 Million USD | 15.1% |
| 2013 | 175.33 Million USD | 12.56% |
| 2012 | 155.77 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.39 Billion USD | -2.34% |
| 2024 Q3 | 2.42 Billion USD | 0.88% |
| 2024 Q2 | 2.4 Billion USD | 0.19% |
| 2023 Q2 | 2.5 Billion USD | 3.5% |
| 2023 Q1 | 2.42 Billion USD | 3.19% |
| 2023 FY | 2.45 Billion USD | 4.55% |
| 2023 Q4 | 2.45 Billion USD | -2.52% |
| 2023 Q3 | 2.51 Billion USD | 0.42% |
| 2022 Q3 | 2.21 Billion USD | 0.32% |
| 2022 Q2 | 2.21 Billion USD | -2.88% |
| 2022 Q1 | 2.27 Billion USD | -1.85% |
| 2022 FY | 2.34 Billion USD | 1.17% |
| 2022 Q4 | 2.34 Billion USD | 5.79% |
| 2021 Q1 | 1.67 Billion USD | 5.04% |
| 2021 FY | 2.31 Billion USD | 45.34% |
| 2021 Q4 | 2.31 Billion USD | 8.72% |
| 2021 Q3 | 2.13 Billion USD | 6.08% |
| 2021 Q2 | 2.01 Billion USD | 19.98% |
| 2020 Q4 | 1.59 Billion USD | 15.5% |
| 2020 Q1 | 1.11 Billion USD | -3.7% |
| 2020 Q3 | 1.38 Billion USD | 17.01% |
| 2020 Q2 | 1.18 Billion USD | 6.2% |
| 2020 FY | 1.59 Billion USD | 38.22% |
| 2019 Q1 | 978.72 Million USD | 41.42% |
| 2019 FY | 1.15 Billion USD | 44.39% |
| 2019 Q4 | 1.15 Billion USD | 10.5% |
| 2019 Q3 | 1.04 Billion USD | 7.46% |
| 2019 Q2 | 972.33 Million USD | -0.65% |
| 2018 Q2 | 566.64 Million USD | 9.39% |
| 2018 Q3 | 618.2 Million USD | 9.1% |
| 2018 Q4 | 692.07 Million USD | 11.95% |
| 2018 FY | 799.56 Million USD | 26.97% |
| 2018 Q1 | 517.98 Million USD | 3.59% |
| 2017 Q1 | 365.55 Million USD | 3.17% |
| 2017 FY | 629.72 Million USD | 57.13% |
| 2017 Q4 | 500.05 Million USD | 8.38% |
| 2017 Q3 | 461.36 Million USD | 8.61% |
| 2017 Q2 | 424.79 Million USD | 16.21% |
| 2016 Q4 | 354.33 Million USD | 3.29% |
| 2016 FY | 400.76 Million USD | 47.52% |
| 2016 Q3 | 343.05 Million USD | 14.74% |
| 2016 Q2 | 298.98 Million USD | 8.82% |
| 2016 Q1 | 274.75 Million USD | 1.13% |
| 2015 FY | 271.67 Million USD | 34.62% |
| 2015 Q4 | 271.67 Million USD | 11.11% |
| 2015 Q3 | 244.51 Million USD | 9.68% |
| 2015 Q2 | 222.92 Million USD | 11.14% |
| 2015 Q1 | 200.57 Million USD | -0.61% |
| 2014 Q1 | 170.85 Million USD | -2.56% |
| 2014 Q4 | 201.81 Million USD | 1.64% |
| 2014 FY | 201.81 Million USD | 15.1% |
| 2014 Q3 | 198.56 Million USD | 6.12% |
| 2014 Q2 | 187.11 Million USD | 9.52% |
| 2013 FY | 175.33 Million USD | 12.56% |
| 2013 Q3 | 163.26 Million USD | 1.63% |
| 2013 Q4 | 175.33 Million USD | 7.39% |
| 2013 Q1 | 143.85 Million USD | -7.65% |
| 2013 Q2 | 160.65 Million USD | 11.68% |
| 2012 Q4 | 155.77 Million USD | 0.0% |
| 2012 FY | 155.77 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -1950.71% |
| Accuray Incorporated | 423.54 Million USD | -479.254% |
| Elevance Health Inc. | 69.52 Billion USD | 96.471% |
| AxoGen, Inc. | 101.16 Million USD | -2325.207% |
| Boston Scientific Corporation | 15.6 Billion USD | 84.279% |
| CVS Health Corporation | 173.09 Billion USD | 98.583% |
| Cardinal Health, Inc. | 48.33 Billion USD | 94.924% |
| Centene Corporation | 58.68 Billion USD | 95.819% |
| DaVita Inc. | 14.87 Billion USD | 83.508% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 95.552% |
| Hologic, Inc. | 4.02 Billion USD | 39.061% |
| Humana Inc. | 30.74 Billion USD | 92.021% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -38.188% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 72.23% |
| Masimo Corporation | 1.67 Billion USD | -46.322% |
| McKesson Corporation | 69.04 Billion USD | 96.447% |
| Patterson Companies, Inc. | 1.89 Billion USD | -29.466% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 67.736% |
| ResMed Inc. | 2 Billion USD | -22.159% |
| Henry Schein, Inc. | 5.42 Billion USD | 54.735% |
| Teladoc Health, Inc. | 2.06 Billion USD | -18.734% |
| Universal Health Services, Inc. | 8.15 Billion USD | 69.915% |
| Veeva Systems Inc. | 1.26 Billion USD | -93.776% |
| Baxter International Inc. | 19.8 Billion USD | 87.614% |
| Becton, Dickinson and Company | 26.98 Billion USD | 90.908% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -20.017% |
| Danaher Corporation | 30.99 Billion USD | 92.085% |
| Stryker Corporation | 21.31 Billion USD | 88.492% |
| Medtronic plc | 39.56 Billion USD | 93.798% |